相似文献
1
Correction: Correction: Wild-Type Mouse Models to Screen Antisense Oligonucleotides for Exon-Skipping Efficacy in Duchenne Muscular Dystrophy.
PLoS One. 2019 Feb 20;14(2):e0212820. doi: 10.1371/journal.pone.0212820. eCollection 2019.
2
Correction: Wild-Type Mouse Models to Screen Antisense Oligonucleotides for Exon-Skipping Efficacy in Duchenne Muscular Dystrophy.
PLoS One. 2018 Nov 15;13(11):e0207817. doi: 10.1371/journal.pone.0207817. eCollection 2018.
3
Designing Effective Antisense Oligonucleotides for Exon Skipping.
Methods Mol Biol. 2018;1687:143-155. doi: 10.1007/978-1-4939-7374-3_10.
4
Tips to Design Effective Splice-Switching Antisense Oligonucleotides for Exon Skipping and Exon Inclusion.
Methods Mol Biol. 2018;1828:79-90. doi: 10.1007/978-1-4939-8651-4_5.
5
In vivo comparison of 2'-O-methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping.
J Gene Med. 2009 Mar;11(3):257-66. doi: 10.1002/jgm.1288.
6
Antisense-induced exon skipping for duplications in Duchenne muscular dystrophy.
BMC Med Genet. 2007 Jul 5;8:43. doi: 10.1186/1471-2350-8-43.
7
Quantitative Antisense Screening and Optimization for Exon 51 Skipping in Duchenne Muscular Dystrophy.
Mol Ther. 2017 Nov 1;25(11):2561-2572. doi: 10.1016/j.ymthe.2017.07.014. Epub 2017 Jul 28.
8
In silico screening based on predictive algorithms as a design tool for exon skipping oligonucleotides in Duchenne muscular dystrophy.
PLoS One. 2015 Mar 27;10(3):e0120058. doi: 10.1371/journal.pone.0120058. eCollection 2015.
9
Development of antisense-mediated exon skipping as a treatment for duchenne muscular dystrophy.
Ann N Y Acad Sci. 2009 Sep;1175:71-9. doi: 10.1111/j.1749-6632.2009.04973.x.
10
In Vitro Multiexon Skipping by Antisense PMOs in Dystrophic Dog and Exon 7-Deleted DMD Patient.
Methods Mol Biol. 2018;1828:151-163. doi: 10.1007/978-1-4939-8651-4_9.
本文引用的文献
1
Correction: Wild-Type Mouse Models to Screen Antisense Oligonucleotides for Exon-Skipping Efficacy in Duchenne Muscular Dystrophy.
PLoS One. 2018 Nov 15;13(11):e0207817. doi: 10.1371/journal.pone.0207817. eCollection 2018.
2
Wild-type mouse models to screen antisense oligonucleotides for exon-skipping efficacy in Duchenne muscular dystrophy.
PLoS One. 2014 Nov 3;9(11):e111079. doi: 10.1371/journal.pone.0111079. eCollection 2014.
Zotero 插件